December 10, 2025 · Form 4 insider transaction
Horn Howard sold 3,081 shares of Ultragenyx Pharmaceutical Inc. at $36.38 per share, a transaction worth $112.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.